 |
|
|
| |
Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO Study
|
| |
| |
17th European AIDS Conference, November 6-9, 2019, Basel
Reported by Jules Levin
M Ait-Khaled,1 M-C Nascimento,1 KA Pappa,2 R Wang,2 J Wright,3 AR Tenorio,2 B Wynne,2
M Aboud,1 MJ Gartland,2 J van Wyk1
1ViiV Healthcare, Brentford, UK; 2ViiV Healthcare, Research Triangle Park, NC, USA; 3GlaxoSmithKline, Stockley Park, UK
|
| |
|
|
|
|
|
